AIMS Meeting Book_MYM2023
First page
Table of contents
Next page
Last page
Agenda
1
Presenter Information
3
Opening Slides
6
Legionella Overview
44
Legionella Testing
50
Lab Perspective on Legionella
54
Challenges of Legionella
57
Slide Number 1
32
Cyclosporiasis
33
C. cayetanensis
34
To date, there are 21 valid species of Cyclospora.
35
Oocysts, Sporocysts, Sporozoites
36
Slide Number 6
37
Slide Number 7
38
FDA Cyclospora Prevention, Response and Research Action Plan
39
New Objectives for The FDA Cyclospora Project starting in FY 2023
40
Advancements
41
NP ISO 9811 (C. cayetanensis)
42
Thank you
43
AIMS- Analytical International Methods & Standards Program
9
Objectives of the Analytical International Methods and Standards Program (AIMS)
10
Additional Challenges in Validation of New Microbiology Technologies
11
Cyclospora Background
12
Slide Number 5
13
Cyclospora Background
14
Cyclospora-Public Health Impact
15
AIMS
16
Testing Landscape
17
Testing Landscape
18
FDA Bacteriological Analytical Manual
19
FDA Bacteriological Analytical Manual
20
Cyclospora and AIMS
21
Cyclospora and AIMS
22
Thank you!
23
SARS COV-2
24
SARS-COV-2
25
SARS-COV-2
26
Variola Virus SMPR 2014.006
27
Variola Virus SMPR 2014.006
28
Slide Number 21
29
Slide Number 22
30
Slide Number 23
31
Made with FlippingBook -
Online catalogs